Vyome Holdings HIND
NASDAQ HIND
$2.06 -0.03 (-1.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Vyome Holdings (HIND) Assets Average (2016 - 2026)

Vyome Holdings (HIND) posted Assets Average of $9.7 million for Q2 2026, up 16.06% on a QoQ basis from $8.3 million in Q1 2026, and up 84.91% year-over-year from $5.2 million in Q2 2025.

Analysis

Vyome Holdings (HIND) Assets Average (2016 - 2026) Analysis & Trends

Vyome Holdings has reported Assets Average for 11 years, with the latest figure at $9.7 million in Q2 2026.

  • On a quarterly basis, Assets Average rose 84.91% year-over-year to $9.7 million in Q2 2026; TTM through Jun 2026 was $9.7 million, a 84.91% increase from a year earlier, with the FY2025 full-year figure at $3.9 million, down 34.59% from the prior year.
  • Assets Average was $9.7 million for Q2 2026 at Vyome Holdings, up from $8.3 million in the prior quarter.
  • The five-year high for Assets Average was $49.1 million in Q1 2022, with the low at $1.3 million in Q4 2024.
  • Average Assets Average over 5 years is $14.0 million, with a median of $9.3 million recorded in 2023.
  • The sharpest annual moves came in 2024 and 2026: Assets Average slumped 85.61% in 2024, then jumped 490.61% in 2026.
  • Over 5 years, Assets Average stood at $18.8 million in 2022, then sank by 50.86% to $9.2 million in 2023, then plunged by 85.61% to $1.3 million in 2024, then jumped by 409.15% to $6.8 million in 2025, then jumped by 42.97% to $9.7 million in 2026.
  • The last three Assets Average figures came in at $9.7 million (Q2 2026), $8.3 million (Q1 2026), and $6.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 94.07 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 52.82 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 26.95 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 41.30 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 11.22 Bn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 5.34 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 30.78 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 5.51 Bn
10 Vyome Holdings 14.46 Mn 6.57 Mn 11,658.00 9.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.68 Mn
Mar 31, 2026 8.34 Mn
Dec 31, 2025 6.77 Mn
Sep 30, 2025 8.04 Mn
Jun 30, 2025 5.24 Mn
Mar 31, 2025 1.41 Mn
Dec 31, 2024 1.33 Mn
Sep 30, 2024 3.84 Mn
Jun 30, 2024 7.31 Mn
Mar 31, 2024 9.45 Mn
Dec 31, 2023 9.25 Mn
Sep 30, 2023 9.84 Mn
Jun 30, 2023 14.10 Mn
Mar 31, 2023 13.75 Mn
Dec 31, 2022 18.81 Mn
Sep 30, 2022 33.42 Mn
Jun 30, 2022 42.99 Mn
Mar 31, 2022 49.08 Mn
Dec 31, 2021 71.66 Mn
Sep 30, 2021 105.40 Mn